The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

Cancer-fighting product developer hires consultant

Indianapolis : IN : USA | 2 months ago  
Views: 0
Becker, will serve as acting chief executive officer of Semafore, which continues to specialize on a compound, the PI3 kinase inhibitor, which interferes with communication between cancer cells and a patient's body. Clinical trials in humans began in March 2007. Joseph Garlich, co-founder and...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Uinta County News | 2 months ago
    Semafore Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other...
  • News Source: The Noblesville Ledger | 2 months ago
    Becker, will serve as acting chief executive officer of Semafore, which continues to specialize on a compound, the PI3 kinase inhibitor, which interferes with communication between cancer cells and a patient's body. Clinical trials in humans began in...

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.